• Home
  • News
  • Athletics Integrity Unit will not appeal USADA decision on American Sprinter Coleman

Athletics Integrity Unit will not appeal USADA decision on American Sprinter Coleman

Athletics Integrity Unit Logo

Press Release

5th September 2019

The Athletics Integrity Unit (AIU) will not appeal the United States Anti-Doping Agency’s (USADA) decision to withdraw its charge against American sprinter Christian Coleman of violation of the whereabouts rules under the World Anti-Doping Code.

USADA announced its decision on Monday following consultation with the World Anti-Doping Agency (WADA) regarding the interpretation of the International Standard for Testing and Investigations (ISTI) concerning the date on which a failure to update an athlete’s whereabouts information should be considered to have occurred.

The AIU, as the body that oversees anti-doping internationally on behalf of the IAAF for the sport of athletics, has the right to appeal such decisions under the World Anti-Doping Code.

AIU chairman, David Howman said: “Based on the facts of the case and clear advice about the interpretation of the current ISTI received from WADA, the AIU has decided not to appeal the USADA decision regarding Christian Coleman. We note that the ISTI is currently under review by WADA and we would support a change in the wording to ensure that in the future, filing failures are recognised when they occuar and never backdated.

Leave a comment

Please login to leave a comment.

Courses

Legal Advisors


Copyright © LawInSport Limited 2010 - 2022. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.